科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Ocular and Stem Cell Translational Research Section,
National Eye Institute,
Ocular and Stem Cell Translational Research Section, National Eye Institute
Davide Ortolan has not added Biography.
If you are Davide Ortolan and would like to personalize this page please email our Author Liaison for assistance.
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model.
Nature communications Dec, 2021 | Pubmed ID: 34911940
Triphasic developmentally guided protocol to generate retinal pigment epithelium from induced pluripotent stem cells.
STAR protocols Sep, 2022 | Pubmed ID: 35880133
Considerations for Developing an Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) Replacement Therapy.
Cold Spring Harbor perspectives in medicine Jul, 2023 | Pubmed ID: 37487631
National Institutes of Health (NIH)
Davide Ortolan1,
Andrei Volkov1,
Arvydas Maminishkis1,
Ruchi Sharma1,
Kapil Bharti1
1Ocular and Stem Cell Translational Research Section, National Eye Institute, National Institutes of Health (NIH)
Zander Esh*,1,
Sharanya Suresh*,1,
Mitra Farnoodian1,
Devika Bose1,
Jiwon Ryu1,
Kapil Bharti1,
Ruchi Sharma1
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。